Literature DB >> 32935388

Lung ultrasound compared to chest X-ray for the diagnosis of CAP in children.

Silvia Bloise1, Domenico Paolo La Regina1, Daniela Pepino1, Elio Iovine1, Marco Laudisa1, Greta Di Mattia1, Ambra Nicolai1, Raffaella Nenna1, Laura Petrarca1, Enrica Mancino1, Antonella Frassanito1, Fabio Midulla1.   

Abstract

BACKGROUND: Community-acquired pneumonia (CAP) represents one of the most common infectious diseases among children. Diagnosis of CAP is mainly clinical. Chest X-ray (CXR) remains the gold standard for the diagnosis in severe or controversial conditions. Recently, some authors have focused on the application of ultrasound in lung diseases but the role of lung ultrasound (LUS) in the diagnosis of CAP is still debated. We aimed to study the concordance between LUS and CXR in evaluating specific signs of CAP. As a secondary aim, we sought to determine the sensitivity and specificity of LUS in CAP diagnosis compared with CXR. Finally, we evaluated the role of LUS during the follow up.
METHODS: We enrolled 68 children (<16 years old) hospitalized from October 2018 to September 2019 with a clinical and radiological diagnosis of CAP (cases: N = 41), or with no respiratory diseases (controls: N = 27), in whom a CXR was performed for clinical indications. All the children underwent LUS during hospitalization. The average time needed to perform LUS was 5-10 min for each child, and 19/41 cases were re-evaluated by LUS and CXR 30 days after discharge.
RESULTS: Lung ultrasound confirmed CAP diagnosis in 40/41 patients. Concordance between the two techniques was K = 0.88 for the right lung and K = 0.70 for the left lung. Lung ultrasound showed a sensitivity of 97% and a specificity of 96% compared with CXR. At the follow up, sensitivity increased to 100% while specificity was 94%.
CONCLUSIONS: Our study showed a potential benefit of LUS compared with CXR in the diagnosis and the follow up of CAP.
© 2020 Japan Pediatric Society.

Entities:  

Keywords:  chest X-ray; child; community-acquired pneumonia; lung disease; lung ultrasound

Year:  2021        PMID: 32935388     DOI: 10.1111/ped.14469

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  5 in total

1.  Response to Comment on Jaworska, J. et al. Consensus on the Application of Lung Ultrasound in Pneumonia and Bronchiolitis in Children. Diagnostics 2020, 10, 935.

Authors:  Anna Komorowska-Piotrowska; Joanna Jaworska; Andrzej Pomiećko; Jakub Wiśniewski; Mariusz Woźniak; Błażej Littwin; Magdalena Kryger; Piotr Kwaśniewicz; Józef Szczyrski; Katarzyna Kulińska-Szukalska; Natalia Buda; Zbigniew Doniec; Wojciech Kosiak
Journal:  Diagnostics (Basel)       Date:  2021-01-04

2.  Comment on Jaworska, J. et al. Consensus on the Application of Lung Ultrasound in Pneumonia and Bronchiolitis in Children. Diagnosticszzm321990 2020, 10, 935.

Authors:  Raffaella Nenna; Elio Iovine; Marco Laudisa; Silvia Bloise; Domenico Paolo La Regina; Fabio Midulla
Journal:  Diagnostics (Basel)       Date:  2021-01-04

3.  ECHOPAEDIA: Echography in Paediatric Patients in the Age of Coronavirus Disease 2019: Utility of Lung Ultrasound and Chest X-Ray in Diagnosis of Community-Acquired Pneumonia and Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia.

Authors:  Ivan Fiorito; Giulia Gori; Tiziano Perrone; Amelia Mascolo; Silvia Caimmi; Ilaria Palumbo; Annalisa De Silvestri; Mariangela Delliponti; Antonio Di Sabatino; Gian Luigi Marseglia
Journal:  Front Pediatr       Date:  2022-02-28       Impact factor: 3.418

4.  Lung ultrasound in children drowning victims in pediatric emergency department.

Authors:  Silvia Bloise; Vanessa Martucci; Alessia Marcellino; Mariateresa Sanseviero; Riccardo Lubrano
Journal:  Pediatr Int       Date:  2022-01       Impact factor: 1.617

5.  Imaging in children with ataxia-telangiectasia-The radiologist's approach.

Authors:  Katarzyna Jończyk-Potoczna; Jakub Potoczny; Aleksandra Szczawińska-Popłonyk
Journal:  Front Pediatr       Date:  2022-09-16       Impact factor: 3.569

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.